awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34810730-01F1FFCA-4C37-48C4-841E-197C5DCBF457
Q34810730-01F1FFCA-4C37-48C4-841E-197C5DCBF457
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34810730-01F1FFCA-4C37-48C4-841E-197C5DCBF457
Is neoadjuvant androgen deprivation therapy beneficial in prostate cancer treated with definitive radiotherapy?
P2860
Q34810730-01F1FFCA-4C37-48C4-841E-197C5DCBF457
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34810730-01F1FFCA-4C37-48C4-841E-197C5DCBF457
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
deb9d86d6f55d889ad6ab86aba20a9fed1029c9a
P2860
Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer.